A 32-year-old woman was diagnosed with schizophrenia approximately 4 years ago. She has been stable on haloperidol for 1 year, following trials with several atypical antipsychotics. Two weeks ago, she began exhibiting mild pseudo-Parkinson's disease symptoms. Because she did not achieve symptom control on so many medications, the PMHNP is reluctant to discontinue the haloperidol and instead chooses to treat the side effect. Which class of medications is the most appropriate for treating these side effects?

Choice A reason: Cholinesterase inhibitors are primarily used in the treatment of Alzheimer’s disease and other dementias. They enhance cholinergic transmission but are not used to treat extrapyramidal symptoms (EPS) like pseudo-Parkinsonism. Choice B reason: Histamine 1 antagonists are typically used for allergic reactions and sleep disorders. They do not address dopamine-related motor side effects caused by antipsychotics. Choice C reason: Alpha 1 adrenergic agonists are used for hypotension and nasal congestion. They do not have a role in managing EPS or Parkinsonian symptoms. Choice D reason: Muscarinic 1 agonists (or more accurately, anticholinergic agents targeting muscarinic receptors) are effective in treating EPS, including pseudo-Parkinsonism. Drugs like benztropine and trihexyphenidyl work by restoring the balance between dopamine and acetylcholine in the basal ganglia, alleviating motor symptoms induced by dopamine blockade from antipsychotics.